Abstract

In 2014, UNAIDS put forth an ambitious target known as 90–90–90, the aims of which included that, by 2020, 90% of all people living with HIV should know their HIV status, 90% of all people with diagnosed HIV should be receiving sustained ART, and 90% of all people receiving ART should have viral suppression.1 In 2016, WHO proposed a global target for the elimination of hepatitis C virus (HCV) by 2030, which included the aims for 80% of eligible people with HCV to be treated, a 90% reduction in incident infections, and a 65% reduction in liver-related mortality.

Highlights

  • In 2014, UNAIDS put forth an ambitious target known as 90–90–90, the aims of which included that, by 2020, 90% of all people living with HIV should know their HIV status, 90% of all people with diagnosed HIV should be receiving sustained ART, and 90% of all people receiving ART should have viral suppression.[1]

  • More recent strategies, including the 2021 UNAIDS Global AIDS Strategy, proposing to end these epidemics acknowledge that structural factors restrict access to HIV and hepatitis C virus (HCV) services and the ability to achieve disease outcomes,[5] they do not explicitly include those structural factors as part of the treatment paradigm

  • people who inject drugs (PWID) are at a 29-times greater risk of acquiring HIV than people who do not inject drugs and account for up to 40% of new HCV infections annually worldwide.[5]

Read more

Summary

Introduction

In 2014, UNAIDS put forth an ambitious target known as 90–90–90, the aims of which included that, by 2020, 90% of all people living with HIV should know their HIV status, 90% of all people with diagnosed HIV should be receiving sustained ART, and 90% of all people receiving ART should have viral suppression.[1]. The global community’s commitment to get people tested and treated for HIV and HCV is virtuous, it is often misaligned with individuals’ basic survival needs, which are integral to treatment for any disease.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.